Sodium Butyrate vs Tributyrin: An Honest Comparison of Butyrate Forms (2026)
Share
By Brandon, founder of Ozzi · Published July 23, 2026 · Updated October 31, 2026
Our butyrate research hub covers all three forms.
What's the actual difference between sodium butyrate and tributyrin?
Sodium butyrate is butyric acid bound to sodium, and tributyrin is three butyrate molecules on a glycerol backbone. Both deliver butyrate, a short-chain fatty acid your gut bacteria already make when they ferment fiber.
“I can smell the butyrate but it goes away once it's mixed with water. It tastes good and it works. It really cuts down my appetite. I'll be ordering more!”
Sodium butyrate is butyric acid paired with sodium. It's a salt, it's water-soluble, and it comes apart quickly once it hits fluid.
Tributyrin is an oil. Three butyrate molecules sit on a glycerol backbone, exactly like any dietary fat, and pancreatic lipase has to cleave them off before the butyrate is free.
There's a third option you'll see less often, which is butyrate bound to an amino acid instead of a mineral or a fat. That's the form we use in our BIOMEnd butyrate supplement, and I'll get to why below.
Does tributyrin really survive the stomach?
Plain tributyrin did not survive the stomach in a validated lab model of digestion: it was rapidly split in the stomach compartment, not the small intestine.
Tributyrin was rapidly cleaved in the gastric compartment, not the small intestine (van Deuren et al., 2023).
Only when the researchers esterified the butyrate with long-chain fatty acids did release shift downstream into the small intestine.
That doesn't make tributyrin bad. It means the delivery advantage is more conditional than the label implies.
What has oral butyrate actually been tested on in humans?
Oral butyrate has been tested in people with type 1 and type 2 diabetes, IBD, fatty liver disease and childhood obesity, in at least six human trials that split about evenly between positive and null. Everything below involved participants who were patients under medical care, studied for medical outcomes, so read it as background on the molecule rather than as anything about a daily wellness drink.
| Study population | Form | Result |
|---|---|---|
| Adults with type 1 diabetes | Sodium butyrate | Fecal butyrate rose. Immune measures unchanged. |
| Children with IBD | Sodium butyrate | No benefit over placebo at 12 weeks. |
| Adults with type 2 diabetes | Sodium butyrate | Mostly null. Some unfavorable lipid shifts. |
| Adults with fatty liver disease | Sodium vs calcium butyrate | Primary endpoint unchanged in both arms. |
| Adults with IBD | Microencapsulated sodium butyrate | Shifted gut bacteria toward SCFA producers. |
| Children with obesity | Sodium butyrate | Positive across several measures. |
Does butyrate raise GLP-1?
Butyrate stimulates the gut cells that release GLP-1 in lab studies, and in people the results are mixed: one 45-day trial saw GLP-1 rise while two other trials saw no change.
For the fuller version, see butyrate and GLP-1 and our primer on what GLP-1 actually is.
Why does butyrate smell so bad, and does the form fix it?
Butyrate smells bad because butyric acid is the compound behind the smell of rancid butter and parmesan left in a hot car, and the form only partly fixes it: no form is odorless. It's genuinely unpleasant, and it's the single biggest reason butyrate supplements are sold as capsules you swallow fast.
Which butyrate form actually reaches your bloodstream?
L-lysine butyrate and sodium butyrate both reached the bloodstream faster and at higher levels than tributyrin in a 2025 human trial, and the two salts were about even.
A randomized, single-blinded, three-arm crossover trial put sodium butyrate, L-lysine butyrate, and tributyrin head to head in 10 healthy men.
| Form | Peak serum butyrate | Time to peak | Total exposure (AUC) |
|---|---|---|---|
| L-lysine butyrate | 4.53 µg/mL | 20 minutes | 189 |
| Sodium butyrate | 2.51 µg/mL | 22.5 minutes | 144 |
| Tributyrin | 0.91 µg/mL | 51.5 minutes | 108 |
Both salts beat tributyrin, clearly. Lysine butyrate hit a peak roughly 5 times higher than tributyrin's and got there about 30 minutes sooner (p=0.007 for peak, p=0.004 for timing). Sodium butyrate beat tributyrin too.
Lysine butyrate did not beat sodium butyrate. The raw averages look like it did. The statistics say otherwise (p=0.340 for peak, p=0.660 for total exposure). Person-to-person variation was enormous, larger than the averages themselves, which the authors attribute to hyper responders. On absorption, the two salts tie, and anyone showing you those raw numbers without the p-values is selling something.
Be careful what you take from this. It's 10 men, one dose, a 210-minute window, and no clinical outcomes of any kind. It's a pharmacokinetic pilot, which answers "does it get in" and says nothing about "does it do anything."
What about L-lysine butyrate, the form in Ozzi?
We use L-lysine butyrate (BIOMEnd), which binds butyrate to the amino acid L-lysine rather than to sodium or a glycerol backbone. Ozzi has 500mg per stick.
There is no human outcome trial on L-lysine butyrate. The 2025 study is a pharmacokinetic pilot in 10 men, it measured absorption and nothing else, and it was funded in part by an industry institute. That is not proof that lysine butyrate produces a health result, and I won't call it clinically proven, because it hasn't earned that word.
Which butyrate form should you actually pick?
L-lysine butyrate comes out first, sodium butyrate is the best value, and tributyrin suits you if you want butyrate further down the gut. Outcomes remain an open question for all three.
Overall pick: L-lysine butyrate. It matches the best-absorbing form in the only human trial that compared them, carries no sodium, and works in a drink instead of a capsule. It's the form we use, so weigh that accordingly, but the reasoning is on the table for you to check.
Sodium butyrate is the value pick, and it has more human trial exposure than the other two combined. It absorbed just as well. Look for microencapsulated or enteric-coated versions, since those are what the better human studies used, and watch the sodium if you're tracking it.
Tributyrin is the pick if your goal is butyrate further down the gut rather than in circulation, or if you want a softgel and you're sensitive to smell. Know going in that most of its supporting research is preclinical and that it came last in serum.
And if your interest in butyrate is really about gut health generally, food does a lot of this work. Our pieces on gut health and GLP-1 and leaky gut and inflammation go deeper there.
Frequently asked questions
Is tributyrin better than sodium butyrate?
Tributyrin is not better than sodium butyrate on absorption. A 2025 human crossover trial measured both in serum, and sodium butyrate reached a peak roughly 3 times higher, about 30 minutes sooner. No human trial has compared them on a health outcome.
Is sodium butyrate bad for blood pressure?
The sodium in a typical serving of sodium butyrate is small relative to a normal diet, but it's a real consideration if you're on a sodium-restricted plan. Amino-acid-bound and triglyceride forms avoid it entirely.
Are there side effects of butyrate?
Reported side effects of butyrate in trials were mild and infrequent, mostly transient nausea or headache. One type 2 diabetes trial noted unfavorable cholesterol shifts, which is worth discussing with your doctor if you have lipid concerns.
Butyrate you can actually drink
Ozzi Crave Crusher puts 500mg of L-lysine butyrate in a cold-water stick with allulose, glucomannan, and chromium. No capsules to swallow. No caffeine.
14-Day Ozzi Challenge: Take it for 14 straight days. If your cravings and food noise aren't quieter, we'll refund your first bag.
About the author
Brandon is the founder of Ozzi. He spends most of his time reading formulation research, answering questions on Reddit with comments enabled, and arguing with suppliers about ingredient doses. He wrote this piece because the butyrate category makes claims its evidence doesn't support, including claims that would benefit his own product.
This article is for general education and is not medical advice. Ozzi is a dietary supplement and is not intended to diagnose, treat, cure, or prevent any disease. Talk to your doctor before starting any supplement, especially if you have a medical condition or take medication.
References
- La Monica MB, Kirby T, Hartshorn SL, Gustat A, Grdic J, Sandrock J. A Pharmacokinetic Comparison of Three Butyrate Products. Journal of Exercise and Nutrition. 2025;8(1):4. NCT06700785 (human)
- van Deuren T, et al. Butyrate and hexanoate-enriched triglycerides increase postprandial systemic butyrate and hexanoate in men with overweight/obesity. Frontiers in Nutrition. 2023. https://doi.org/10.3389/fnut.2022.1066950 (human)
- Roshanravan N, et al. Effect of butyrate and inulin supplementation on glycemic status, lipid profile and glucagon-like peptide 1 level in patients with type 2 diabetes: a randomized double-blind, placebo-controlled trial. Horm Metab Res. 2017. https://pubmed.ncbi.nlm.nih.gov/28962046/ (human)
- Amiri P, et al. Expression of PGC-1α, PPAR-α and UCP1 genes, metabolic and anthropometric factors in response to sodium butyrate supplementation in patients with obesity: a triple-blind, randomized placebo-controlled clinical trial. Eur J Clin Nutr. 2025. https://pubmed.ncbi.nlm.nih.gov/39448815/ (human)
- Mitrović M, et al. Exploring the Potential of Oral Butyrate Supplementation in Metabolic Dysfunction-Associated Steatotic Liver Disease. International Journal of Molecular Sciences. 2025. https://doi.org/10.3390/ijms26125561 (human)
- de Groot PF, et al. Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes. Diabetologia. 2020. https://doi.org/10.1007/s00125-019-05073-8 (human)
- Pietrzak A, et al. Sodium Butyrate Effectiveness in Children and Adolescents with Newly Diagnosed Inflammatory Bowel Diseases. Nutrients. 2022. https://doi.org/10.3390/nu14163283 (human)
- Khosravi Z, et al. The effects of butyrate supplementation on glycemic control, lipid profile, blood pressure, nitric oxide level and glutathione peroxidase activity in type 2 diabetic patients. Clinical Nutrition ESPEN. 2022. https://doi.org/10.1016/j.clnesp.2022.03.008 (human)
- Facchin S, et al. Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease. Neurogastroenterology & Motility. 2020. https://doi.org/10.1111/nmo.13914 (human)
- Coppola S, et al. Therapeutic Effects of Butyrate on Pediatric Obesity: A Randomized Clinical Trial. JAMA Network Open. 2022. https://doi.org/10.1001/jamanetworkopen.2022.44912 (human)
- Yang N, et al. Tributyrin alleviates gut microbiota dysbiosis to repair intestinal damage in antibiotic-treated mice. PLoS One. 2023. https://doi.org/10.1371/journal.pone.0289364 (rodent)
- Cresci GA, et al. Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury. Journal of Gastroenterology and Hepatology. 2017. https://doi.org/10.1111/jgh.13731 (rodent and in vitro)
- Siddiqui MT, et al. The Postbiotic Butyrate Mitigates Gut Mucosal Disruption Caused by Acute Ethanol Exposure. International Journal of Molecular Sciences. 2024. https://doi.org/10.3390/ijms25031665 (rodent and human cell)
- Cresci G, et al. Lactobacillus GG and tributyrin supplementation reduce antibiotic-induced intestinal injury. JPEN. 2013. https://doi.org/10.1177/0148607113486809 (rodent)
- Ullah S, et al. Comparative Effects of Dietary Supplementations with Microencapsulated Sodium Butyrate, Glycerol Monolaurate and Tributyrin. Animals. 2025. https://doi.org/10.3390/ani15060810 (fish)
Research sourced via PubMed.
